Agenda: 2024 Avoca Quality Consortium Summit

Tuesday, May 14, 2024
10:00 AM																Framing the Industry's Imperative to Maximize Time to Modernize Clinical Trials; Welcome and Summit Overview • Michelle Webb - Vice President, Avoca Quality Consortium - Avoca, A WCG Company (Speaker)
10:10 AM																Opening Remarks • Andy Lee - Senior Vice President, Head of Global Clinical Trial Operations - Merck (Speaker)
10:30 AM																Artificial Intelligence Discussion: How to Leverage AI to Maximize Time • Silvio Galea - Chief Data & Analytics Officer - WCG (Facilitator) • Anya Derbij, MD - Vice President, Head Clinical Operations - Cellphire Therapeutics, Inc. (Panelist) • Jacob Ferro - Executive Vice President, Chief Information, Technology & Product Officer - Clario (Panelist) • Maxwell Lawson - Head of Digital Process Innovation and AI in Drug Development - Novartis (Panelist) • Andrew Mackinnon - Senior Vice President & Executive General Manager - Medable, Inc. (Panelist) • Dominic De Bellis, PhD - Executive Director, Medical Writing - Merck (Panelist)
11:15 AM																Sustainability Discussion: The Impact of Clinical Trials on the Global Climate Crisis and the Imperative for Timely Change • Michael J Cohen, MSc, MBA - Senior Director, Environmental Sustainability \| Digital and Decentralized Solutions - PPD (Facilitator) • Neil Mackillop - Senior Medical Director Global Clinical Development - AstraZeneca (Panelist) • Carly Santer, PhD - Strategic Initiatives Project Leader & Sustainability Activator - Bayer (Panelist) • Jürgen Wieland - Development Environmental Sustainability Lead - Novartis Pharma AG, Basel (Panelist)
12:00 PM																How integrative therapies and nutrition move the needle on cancer patient care • Sue Weldon - CEO and Founder - Unite for HER and 2021 AstraZeneca Catalyst for Care Award Winner (Speaker)
12:20 PM																Break
1:00 PM																Remarks by WCG CEO Sam Srivastava • Sam Srivastava - CEO - WCG (Speaker)
1:15 PM																Avoca Industry Research: Potential Changes in Regulatory Guidance under ICH E6 (R3) • Cristin MacDonald, PhD - Vice President, Client Delivery - Avoca, A WCG Company (Speaker)
1:45 PM																Day 1 Adjourn
Wednesday, May 15, 2024
10:00 AM																Welcome • Michelle Webb - Vice President, Avoca Quality Consortium - Avoca, A WCG Company (Speaker)
10:05 AM																A patient’s lifelong journey with sickle cell disease, the clinical research that changed her life, and her passionate efforts in patient advocacy • Wunmi Bakare - Patient and Advocacy Trailblazer (Speaker)
10:30 AM																Challenges and Solutions for Advancing Diversity, Equity and Inclusion • Emery Brandy - Senior Manager-Client Delivery - WCG Clinical (Facilitator) • Wunmi Bakare - Patient and Advocacy Trailblazer (Speaker) • Stacey Bledsoe - Head of Global Clinical Trial Diversity and Inclusion - Gilead (Panelist) • Brittany Gerald - Associate Director, Clinical Trial Diversity & Inclusion - Moderna (Panelist) • William Maybee - Community Relations Coordinator - Roswell Park (Panelist)
11:15 AM																Quality Discussion: Do we need to slow down to speed up? Leveraging ICH E6 (R3) to drive efficiency in the clinical trial process • Karen Harvey - Senior Director, Avoca Quality Consortium - Avoca, A WCG Company (Facilitator) • Rachel Lara - Vice President, Regional Operational Delivery, Americas, Clinical Operations - PPD, part of Thermo Fisher Scientific (Panelist) • Joshua Petersen - Director of Quality Assurance - Velocity Clinical Research (Panelist) • Hanne Storgaard Schultz - Regional Director, Clinical Quality Management EMEA (RCQM EMEA 4) \| Quality & Continuous Improvement (QCI) - Global Clinical Trial Operations (GCTO) - MSD (Panelist) • Alethea Wilson - Director, Risk & Analytics Lead \| Risk Evaluation & Adaptive Integrated Monitoring (REAIM) \| Quality & Continuous Improvement \| Global Clinical Trial Operations (GCTO) - Merck (Panelist)
12:00 PM																Break
12:30 PM																Workshop: Saving Time by Applying a Risk-Based Approach to Provider Qualification and Oversight • Janis Hall - Senior Consultant - Avoca, A WCG Company (Facilitator) • Karen Harvey - Senior Director, Avoca Quality Consortium - Avoca, A WCG Company (Facilitator)
2:00 PM																Summit Adjourn